Tag: Policy
Union Minister Shivraj Singh Chouhan inaugurates Asian Seed Congress 2025 in...
Chouhan urges the private sector to work jointly with the Government on matters related to seeds
DBT completes special campaign 5.0 with 100% achievement in cleanliness and...
The preparatory phase of the campaign ran from September 15–30, followed by the main implementation phase through October
Vigilance must become an institutional habit: JP Nadda
Union Health Minister J.P. Nadda administers Integrity Pledge to officers and staff of Health Ministry as part of Vigilance Awareness Week 2025
India must move towards a self-sustainable research ecosystem: Dr Jitendra Singh
Addressing Bengaluru Diabetes Conference, Dr Jitendra Singh calls upon healthcare sector to move away from overdependence on government funding and encourage a culture of extensive private-sector participation
DBT–BIRAC and UPPPC ink landmark MoU to boost biotech & pharma...
The centre–state collaboration, signed in New Delhi in the presence of senior government leaders, marks a pivotal step towards India’s $1 trillion bioeconomy
WHO COPCORD survey reveals 1 in 6 Indians living with Arthritis
The meeting presented findings from the largest-ever multi-site community survey conducted under the WHO COPCORD (Community Oriented Program for Control of Rheumatic Diseases) model
Dr Renu Swarup elected as fellow of INSA, honoured for leadership...
Over her three-decade career she has contributed significantly in areas such as Biotechnology policy development, including the Biotechnology Vision (2001) and subsequent national strategies
CIDSCON 2025: Judicious use of antibiotics essential to fight AMR: Experts
The conference stressed a multi-dimensional approach required to address Antimicrobial Resistance (AMR), focusing on the right approach and strengthening awareness
AiMeD welcomes govt’s GST rate cut & MRP implementation relief for...
Recalling or re-labelling of existing stock already released in the market will not be mandatory
GST overhaul brings relief to patients and industry alike
Exemptions for life-saving drugs and sharp cuts on diagnostics, Medtech, and insurance reshape India’s healthcare affordability landscape.